Nothing Special   »   [go: up one dir, main page]

Bakay, 1992 - Google Patents

Central Nervous System Grafting: Animal and Clinical Results.

Bakay, 1992

Document ID
8026988319259870375
Author
Bakay R
Publication year
Publication venue
Stereotactic & Functional Neurosurgery

External Links

Snippet

In the 2 years since this topic was reviewed, there have been dramatic changes in our understanding of the basic science of central nervous system transplantation, as well as further realization of the crude state in which we find the clinical application of this …
Continue reading at search.ebscohost.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells

Similar Documents

Publication Publication Date Title
EP0650377B1 (en) Neuroinhibitory compounds released by implanting devices
Lindvall Transplantation into the human brain: present status and future possibilities.
Freed et al. Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials
Drucker-Colín et al. Cell transplantation for Parkinson's disease: present status
Shoichet et al. Cell delivery to the central nervous system
Sladek et al. Nerve-cell grafting in Parkinson's disease
Goetz et al. Neurosurgical horizons in Parkinson's disease
WO1994001166A9 (en) Implanting devices for release of neuroinhibitory compounds
Perlow Brain grafting as a treatment for Parkinson's disease
Nilsen et al. Focal treatment for refractory epilepsy: hope for the future?
Bakay Central Nervous System Grafting: Animal and Clinical Results.
Olson Grafts and growth factors in CNS: basic science with clinical promise
Will et al. Nerve growth factor: effects on CNS neurons and on behavioral recovery from brain damage
Boyer et al. The history, theory, and present status of brain transplantation
Olson Reparative strategies in the brain: treatment strategies based on trophic factors and cell transfer techniques
Chen et al. The Effect of Priorin VitroExposure of Donor Cells to Trophic Factors in Neurotransplantation
FIANDACA BRAIN GRAFTING FOR PARKINSON'S DISEASE: EXPERIMENTAL, CLINICAL, AND IMMUNOLOGICAL CONSIDERATIONS
Bakay Neurotransplantation: A clinical update
Rosenfeld et al. Neural transplantation for Parkinson's disease: a critical appraisal
Meyerson et al. Advances in Stereotactic and Functional Neurosurgery 10
Fiandaca et al. New insights and technologies in brain grafting
Brundin et al. Transplantation in Parkinson’s disease
Williams Cell implantation in Parkinson's disease.
Bohn et al. Bilateral recovery of striatal dopamine after unilateral adrenal grafting into the striatum of the 1‐methyl‐4‐(2′ methylphenyl)‐1, 2, 3, 6‐tetrahydropyridine (2′ CH3‐MPTP)‐treated mouse
Cobber et al. Maintenance of sympathetic innervation into the hippocampal formation requires a continuous local availability of nerve growth factor